Santen, JP3336000009

Santen schedules JPY 21.00 dividend payment for Santen stock

Published on 10/20/2026 at 18:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Santen stands 17.82 percent below its EUR 11.90 52-week high. Santen stock costs EUR 9.78 on October 20, 2026 at 6:34 p.m. CEST.

Dividend and subsidiary update

  • Santen has scheduled a JPY 21.00 per-share dividend for November 30, 2026.
  • Santen disclosed a consolidated subsidiary bankruptcy petition on October 16, 2026.
  • Santen stock costs EUR 9.78 at Lang & Schwarz on October 20, 2026, 17.82 percent below its EUR 11.90 52-week high.
Santen, JP3336000009, Illustration mit AI erstellt.

Santen Pharmaceutical (JP3336000009) has scheduled a JPY 21.00 per-share dividend for payment on November 30, 2026, according to a September 22 update from Simply Wall St. At Lang & Schwarz, Santen stock was trading at EUR 9.78 on October 20, 2026 at 6:34 p.m. CEST.

The dividend is due to be paid on November 30, 2026, while the ex-dividend date was September 29, 2026. The payment gives investors a dated shareholder-return item separate from the company's operating updates.

Subsidiary petition adds a risk item

Santen disclosed a petition for the commencement of bankruptcy proceedings involving a consolidated subsidiary on October 16, 2026. The notice appears in the company's investor-relations materials, linked through Santen. The available notice identifies the legal process but does not provide a quantified earnings effect.

Stock sits below its yearly high

The euro quotation is EUR 2.12 below the EUR 11.90 52-week high and EUR 1.73 above the EUR 8.05 low. That places the stock 17.82 percent below its high and 21.49 percent above its low, using the 52-week range published for the Frankfurt quotation on October 15, 2026.

Santen's market capitalization was JPY 555.0 billion on October 20, 2026, while its Tokyo price was JPY 1,727.50. The Tokyo quotation was 0.06 percent above the previous session's JPY 1,726.50, a separate home-market measure from the euro quotation.

Results date follows the dividend

Santen is scheduled to report its second-quarter fiscal 2027 results on November 5, 2026, according to the dated company-event record carried by Simply Wall St. The November reporting date comes before the November 30 dividend payment and gives the next scheduled point for a fresh operating update.

What the price position indicates

The current euro quotation is closer to the yearly low than the yearly high, while the home-market valuation shows a price-to-earnings ratio of 14.54. For investors, the next useful comparison will be whether the November results change that valuation or leave the dividend as the clearer near-term shareholder-return fact.

Trading position

Santen stock was trading at EUR 9.78 at Lang & Schwarz on October 20, 2026 at 6:34 p.m. CEST, 17.82 percent below the EUR 11.90 52-week high. The further course of trading is shown by the continuously updated real-time quote of Santen stock.

Santen market profile

  • Company: Santen Pharmaceutical Co., Ltd.
  • ISIN: JP3336000009
  • Ticker: 4536
  • Primary exchange: TSE
  • Price Lang & Schwarz (as of October 20, 2026, 6:34 p.m. CEST): EUR 9.78
  • Market capitalization: JPY 555.0 billion (as of October 20, 2026)
  • 52-week range: EUR 8.05-EUR 11.90 (as of October 15, 2026)
  • Sector / Industry: Healthcare / Drug Manufacturers - General

Market context: Market report Nikkei 225.

More news and analyses on Santen stock

Disclaimer...
en | JP3336000009 | SANTEN | boerse | 70376088 | bgmi